SUBSCRIBE
SUBSCRIBE

Novo Nordisk A/S Release: Research Update

September 26, 2008 | 
1 min read

BAGSVAERD, DENMARK--(Marketwire - September 26, 2008) - Novo Nordisk provides update on corporate strategy at its Capital Markets Day

Europe
MORE ON THIS TOPIC
Pictured: Exterior view of the headquarters of the
FDA
Sanofi and Regeneron’s Dupixent Snags First Biologic Approval in COPD
September 27, 2024
 · 
2 min read
 · 
Kate Goodwin
Corporate headquarters of Novo Nordisk. A pharmaceutical company headquartered in Denmark. Copenhagen, Denmark - august 12, 2023.
Regulatory
Novo Secures EU Panel’s Backing for Cardiovascular Use of Wegovy
September 20, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: AstraZeneca building in Gothenburg/iStoc
Bladder cancer
AstraZeneca’s Perioperative Imfinzi ‘Significantly Extends Survival’ in Type of Bladder Cancer
September 16, 2024
 · 
2 min read
 · 
Tristan Manalac
GSK's headquarters in West London
Lung cancer
GSK, iTeos Score Phase II Win for Jemperli-TIGIT Combo in NSCLC
September 16, 2024
 · 
2 min read
 · 
Tristan Manalac